Deep initial discounts of up to 40% versus AbbVie’s Humira (adalimumab) original have won Biogen’s Imraldi alternative a nationwide supply contract with Germany’s GWQ group of health insurance funds.
Deep initial discounts of up to 40% versus AbbVie’s Humira (adalimumab) original have won Biogen’s Imraldi alternative a nationwide supply contract with Germany’s GWQ group of health insurance funds.
“With a discount of up to 40%, Biogen’s product offers by far the greatest price advantage over the Humira original,”...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
